CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy

被引:0
|
作者
Dan Wang
Ling Chen
Chengbi Li
Quanxin Long
Qing Yang
Ailong Huang
Hua Tang
机构
[1] The Second Affiliated Hospital,Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases
[2] Chongqing Medical University,undefined
[3] The People’s Hospital of Rongchang District,undefined
关键词
CRISPR/Cas9; UCNP; Biomimetic nanoparticles; On-demand release; HBV; Antiviral therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Editorial: Current approaches to CRISPR/Cas9 delivery
    Uludag, Hasan
    Aliabadi, Hamidreza Montazeri
    Gasiunas, Giedrius
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [32] Cell-targeted gene modification by delivery of CRISPR/Cas9 RNPs in pseudotyped lentivirus-derived nanoparticles
    Nielsen, I.
    Rovsing, A. B.
    Thomsen, E. A.
    Ruzo, A.
    Boggild, A.
    Nedergaard, F.
    Boesen, T.
    Degn, S. E.
    Shah, J. V.
    Mikkelsen, J. G.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A286 - A286
  • [33] Mulberry Leaf Lipid Nanoparticles: a Naturally Targeted CRISPR/Cas9 Oral Delivery Platform for Alleviation of Colon Diseases
    Ma, Lingli
    Ma, Ya
    Gao, Qiang
    Liu, Shengsheng
    Zhu, Zhenhua
    Shi, Xiaoxiao
    Dai, Fangyin
    Reis, Rui L.
    Kundu, Subhas C.
    Cai, Kaiyong
    Xiao, Bo
    SMALL, 2024, 20 (25)
  • [34] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):
  • [35] Development of Nanoparticles to Deliver a CRISPR/Cas9 Therapy for Duchenne Muscular Dystrophy
    Emami, Michael R.
    Young, Courtney S.
    Ji, Ying
    Pyle, April D.
    Meng, Huan
    Spencer, Melissa J.
    MOLECULAR THERAPY, 2018, 26 (05) : 284 - 285
  • [36] Nanoparticles for CRISPR-Cas9 delivery
    Glass, Zachary
    Li, Yamin
    Xu, Qiaobing
    NATURE BIOMEDICAL ENGINEERING, 2017, 1 (11): : 854 - 855
  • [37] ROS-responsive polypeptides for intracellular protein delivery and CRISPR/Cas9 gene editing
    Tan, Echua
    Wan, Tao
    Yu, Chunlei
    Fan, Qianqian
    Liu, Wenbang
    Chang, Hong
    Lv, Jia
    Wang, Hui
    Li, Dali
    Ping, Yuan
    Cheng, Yiyun
    NANO TODAY, 2022, 46
  • [38] Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
    Kim, Minse
    Hwang, Youngwoo
    Lim, Seongyu
    Jang, Hyeon-Ki
    Kim, Hyun-Ouk
    PHARMACEUTICS, 2024, 16 (09)
  • [39] Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast
    Hryhorowicz, Magdalena
    Grzeskowiak, Bartosz
    Mazurkiewicz, Natalia
    Sledzinski, Pawel
    Lipinski, Daniel
    Slomski, Ryszard
    MOLECULAR BIOTECHNOLOGY, 2019, 61 (03) : 173 - 180
  • [40] Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment
    Aghamiri, Shahin
    Talaei, Sam
    Ghavidel, Afshin Abdi
    Zandsalimi, Farshid
    Masoumi, Saeid
    Hafshejani, Nahid Heidari
    Jajarmi, Vahid
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 56